EORTC QLQ C-30 | SPCe | Controlf |
|---|
| Â | A1 | A2 | A3 | A1 | A2 | A3 |
Physical functioning | 54 | 60 | 82 | 56 | 54 | 51 |
Emotional functioning | 62 | 70 | 78 | 64 | 64 | 70 |
Fatigue | 56 | 58 | 54 | 58 | 64 | 72 |
Pain | 42 | 40 | 40 | 46 | 50 | 58 |
Appetite loss | 34 | 32 | 32 | 32 | 40 | 52 |
Global health status | 62 | 66 | 76 | 60 | 54 | 52 |
- aThe questionnaire is composed of both multi-item scale and single item measures that range in score from 0 to 100.
- bA high scale score represents a higher response level for physical functioning and emotional functioning.
- cA high score for the global health status represents high QoL.
- dA high score for fatigue, pain, and appetite loss represents a high level of symptoms.
- eStatistically significant results in PCS group pre-treatment period vs. post-treatment period (p < 0.05).
- fStatistically significant results in PCS group vs. control group at the post-treatment period (p < 0.05) SPC – protein-caloric supplemented group.
- A1 : one week before radiotherapy.
- A2 : 30 days after the beginning of radiotherapy.
- A3 : 60 days after the beginning of radiotherapy.
